ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 29.6 | 26.5 | 18.8 |
| Other income | 2.2 | 2.6 | 2.0 |
| Total income | 31.8 | 29.1 | 20.9 |
| Profit before exceptional items & tax | 6.9 | 8.3 | 3.7 |
| Profit before tax | 6.9 | 8.3 | 3.7 |
| Net profit | 5.4 | 5.2 | 2.6 |
| Operating margin | 21.7% | 28.5% | 17.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +107.70% |
|---|---|
| Net profit, quarter on quarter | +3.80% |
| Revenue, year on year | +57.40% |
| Operating profit, year on year | +176.50% |
| Operating profit, quarter on quarter | -17.50% |
BSE results filing, NSE: CORALAB. Figures extracted from the filing.
Coral Laboratories Ltd: key numbers
- Share price
- ₹547.90
- Market cap
- ₹195.7 Cr
- Revenue (annual)
- ₹85.90 Cr
- Net profit (annual)
- ₹16.38 Cr
- P/E (TTM)
- 10.2×Sector 43.8×
- Promoter holding
- 71.51%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Coral Laboratories Ltd
All →Coral Laboratories Board Meeting Date
Coral Laboratories will hold a board meeting on 14 Nov 2026 to consider unaudited standalone half-yearly results for the period ended September 2026, plus other business. Trading window closes from 1 Oct to 16 Nov 2026.
Coral Laboratories Other Announcement
The company has filed its quarterly shareholding pattern statement for the quarter ended September 30, 2026, as required under SEBI Regulation 31.
Coral Laboratories Annual General Meeting
Coral Laboratories Limited held its 44th Annual General Meeting on September 29, 2026. Shareholders approved the FY2025-26 audited financial statements, declared a final dividend, and re-appointed retiring directors.
Coral Laboratories Board Meeting Outcome
Coral Laboratories Ltd's board approved the Cost Audit Report for fiscal year 2025-26. This routine meeting involved no other material financial or business decisions.
Coral Laboratories Board Meeting Date
Coral Laboratories intimated BSE of a board meeting scheduled for 25 September 2026. The agenda includes approval of the cost audit report for FY 2025-26.
Coral Laboratories Annual General Meeting
Coral Laboratories Limited has issued a notice for its Annual General Meeting scheduled for June 29, 2026. Agenda items include adoption of financial statements and dividend declaration.